SCHEMBL8318162

SCHEMBL8318162

O=C(c1ccc(Cl)cc1)c1ccccc1N=C=S

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A1 P22736 1/20 0.54
KMT2A Q03164 2/20 0.42
MAPT P10636 1/20 0.41
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
SRD5A2 P31213 1/20 0.41
MAPK1 P28482 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
ALDH1A1 P00352 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C19 P33261 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HPGD P15428 1/20 0.40
LMNA P02545 1/20 0.40
RAB9A P51151 2/20 0.40
MEN1 O00255 1/20 0.40
POLB P06746 1/20 0.39
KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5145030 0.87 AKR1C3 (0.50) NR4A1KMT2AMAPTSRD5A2L3MBTL1
SCHEMBL11445577 0.82 S100B (0.58) NR4A1KMT2AMAPTMAPK1ALDH1A1
SCHEMBL3444656 0.77 NR4A1 (0.84) NR4A1KMT2AMAPTCES2CES1
SCHEMBL21847220 0.77 NR4A1 (0.45) NR4A1KMT2AMAPTSRD5A2MAPK1
SCHEMBL6573452 0.76 ALDH1A1 (0.44) MAPTCES2CES1ALDH1A1CYP1A2
SCHEMBL29498981 0.75 AKR1C3 (0.44) NR4A1MAPTL3MBTL1ALDH1A1CYP2C9
SCHEMBL28285905 0.75 AKR1C3 (0.44) NR4A1MAPTL3MBTL1ALDH1A1CYP2C9
SCHEMBL11492387 0.75 RECQL (0.57) KMT2AMAPTCES2CES1ALDH1A1
SCHEMBL1110888 0.74 ALDH1A1 (0.50) NR4A1KMT2AMAPTMAPK1L3MBTL1
SCHEMBL28451754 0.74 NR4A1 (0.85) NR4A1MAPTCES2CES1SRD5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0934940-A1 CYTOKINE PRODUCTION INHIBITORS, TRIAZEPINE COMPOUNDS, AND INTERMEDIATES THEREOF Japan Tobacco Inc. (JP) 1999-08-11 EP disclosed
US-5807850-A Therapeutic agent for osteoporosis and triazepine compound JAPAN TOBACCO, INC. (JP) 1998-09-15 US disclosed
EP-0792880-A1 OSTEOPOROSIS REMEDY AND TRIAZEPINE COMPOUND Japan Tobacco Inc. (JP) 1997-09-03 EP disclosed